CME Group Inc. (NASDAQ:CME) Holdings Lifted by Solidarity Wealth LLC

Solidarity Wealth LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 48.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,610 shares of the financial services provider’s stock after buying an additional 6,100 shares during the period. CME Group makes up about 1.1% of Solidarity Wealth LLC’s holdings, making the stock its 29th biggest position. Solidarity Wealth LLC’s holdings in CME Group were worth $4,106,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the business. Salomon & Ludwin LLC purchased a new stake in shares of CME Group during the first quarter worth $28,000. Y.D. More Investments Ltd acquired a new stake in shares of CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. grew its stake in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares in the last quarter. Asset Dedication LLC raised its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its stake in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the transaction, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CME. Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday. Barclays raised their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Price Performance

Shares of CME Group stock opened at $227.26 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $81.83 billion, a PE ratio of 25.85, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The firm has a fifty day moving average price of $220.05 and a two-hundred day moving average price of $209.23. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business earned $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.